ReviewThe Lancet. Oncology2020
CAR T-cell product performance in haematological malignancies before and after marketing authorisation.
Magdi Elsallab et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
49 papers cite it
this paperpooled ittrialcites it